Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,439Revenue (TTM) $M943Net Margin (%)3.7Altman Z-Score3.1
Enterprise Value $M2,457EPS (TTM) $0.5Operating Margin %12.1Piotroski F-Score5
P/E(ttm)70.3Beneish M-Score-2.4Pre-tax Margin (%)5.6Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %-2.4Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow28.8y-y EBITDA Growth Rate %38.4ROA % (ttm)1.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)3.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.8ROIC % (ttm)6.3Gross Margin Increase y-yN

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IPXLJoel Greenblatt 2016-03-31 Add0.16%$30.73 - $42.76
($35.27)
$ 33.16-6%Add 2317.15%478,620
IPXLNWQ Managers 2016-03-31 Reduce-0.01%$30.73 - $42.76
($35.27)
$ 33.16-6%Reduce -3.89%190,660
IPXLNWQ Managers 2015-12-31 Reduce-0.21%$34.53 - $44.76
($40.13)
$ 33.16-17%Reduce -66.75%198,378
IPXLJoel Greenblatt 2015-12-31 Buy 0.01%$34.53 - $44.76
($40.13)
$ 33.16-17%New holding19,801
IPXLNWQ Managers 2015-09-30 Reduce-0.07%$33.27 - $50.42
($45.1)
$ 33.16-26%Reduce -16.00%596,619
IPXLNWQ Managers 2015-06-30 Reduce-0.13%$44.44 - $51.31
($47.45)
$ 33.16-30%Reduce -24.12%710,302
IPXLGeorge Soros 2015-06-30 Sold Out -0.03%$44.44 - $51.31
($47.45)
$ 33.16-30%Sold Out0
IPXLGeorge Soros 2015-03-31 Buy 0.03%$30.2 - $47.3
($39.79)
$ 33.16-17%New holding61,206
IPXLJoel Greenblatt 2015-03-31 Sold Out -0.02%$30.2 - $47.3
($39.79)
$ 33.16-17%Sold Out0
IPXLNWQ Managers 2015-03-31 Add0.02%$30.2 - $47.3
($39.79)
$ 33.16-17%Add 3.32%936,127
IPXLMario Gabelli 2015-03-31 Sold Out -0.0011%$30.2 - $47.3
($39.79)
$ 33.16-17%Sold Out0
IPXLNWQ Managers 2014-12-31 Reduce-0.1%$23.63 - $32.75
($29.3)
$ 33.1613%Reduce -30.25%906,043
IPXLJoel Greenblatt 2014-12-31 Add0.01%$23.63 - $32.75
($29.4)
$ 33.1613%Add 136.17%79,609
IPXLMario Gabelli 2014-12-31 Buy $23.63 - $32.75
($29.3)
$ 33.1613%New holding6,775
IPXLNWQ Managers 2014-09-30 Add0.08%$22.77 - $30.68
($25.55)
$ 33.1630%Add 31.90%1,298,995
IPXLJoel Greenblatt 2014-09-30 Buy 0.01%$22.77 - $30.68
($25.55)
$ 33.1630%New holding33,709
IPXLNWQ Managers 2014-06-30 Buy 0.3%$23.6 - $30.68
($26.93)
$ 33.1623%New holding984,841
IPXLJoel Greenblatt 2012-03-31 Sold Out -0.05%$18.64 - $24.37
($20.72)
$ 33.1660%Sold Out0
IPXLJoel Greenblatt 2011-12-31 Reduce-0.47%$16.53 - $20.75
($18.65)
$ 33.1678%Reduce -88.51%21,057
IPXLJoel Greenblatt 2011-09-30 Reduce-0.38%$15.26 - $21.56
($19.54)
$ 33.1670%Reduce -40.22%183,187
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IPXL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHLOSSBERG MARK ASVP and General Counsel 2015-09-11Sell7,457$43.3-23.42view
NESTOR MICHAELPresident, Impax Pharm. 2015-09-10Sell5,000$43.56-23.88view
FLEMING NIGELDirector 2015-08-31Sell29,166$41.02-19.16view
MARKBREITER MICHAELDirector 2015-08-31Sell28,000$41.7-20.48view
BENET LESLIE ZDirector 2015-08-31Sell20,000$40.92-18.96view
SCHLOSSBERG MARK ASVP and General Counsel 2015-08-27Sell4,649$43.41-23.61view
TERRERI PETER RDirector 2015-08-27Sell4,833$43.93-24.52view
MARKBREITER MICHAELDirector 2015-08-26Sell19,399$42.24-21.5view
HSU LARRYDirector 2014-06-06Sell100,000$28.3816.84view
TERRERI PETER RDirector 2014-05-27Sell3,000$2818.43view

Quarterly/Annual Reports about IPXL:

News about IPXL:

Articles On GuruFocus.com
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Pharmaceutical Stocks Hold Prominent Positions in Kyle Bass' 3rd-Quarter Activity Nov 27 2015 
Kyle Bass Goes Fishing for These 3 New Holdings Nov 26 2015 
Alan Fournier's Highest Performing Stocks Jul 15 2015 
Alan Fournier's Most Heavily Weighted Trades In Q1 2015 May 28 2015 
Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
President and CEO of Impax Laboratories Inc. (IPXL) Larry Hsu Bought 10,000 Shares Aug 17 2011 
Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 5,000 Shares Aug 12 2010 

More From Other Websites
Shkreli's former company beats Impax demand to block drug sales May 18 2016
IMPAX LABORATORIES INC Financials May 18 2016
IMPAX LABORATORIES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... May 18 2016
Impax Laboratories, Inc. :IPXL-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
Impax Asset Management Is Betting Heavily on Water Stocks May 15 2016
Edited Transcript of IPXL earnings conference call or presentation 10-May-16 12:30pm GMT May 10 2016
IMPAX LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... May 10 2016
Q1 2016 Impax Laboratories Inc Earnings Release - Before Market Open May 10 2016
Impax Labs reports 1Q loss May 10 2016
Impax Labs reports 1Q loss May 10 2016
Impax Reports First Quarter 2016 Financial Results May 10 2016
Impax Reports First Quarter 2016 Financial Results May 10 2016
Specialty Pharma Stocks to Report Q1 on May 10: AGN, IPXL May 09 2016
Is a Surprise Coming for Impax Laboratories (IPXL) This Earnings Season? May 09 2016
Impax to Present at the Bank of America Merrill Lynch 2016 Health Care Conference May 04 2016
Impax to Present at the Bank of America Merrill Lynch 2016 Health Care Conference May 04 2016
Former Shkreli firm responsible for 5,000% drug hike sued May 02 2016
Impax Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : IPXL-US : May 2,... May 02 2016
Impax to Report First Quarter 2016 Results on May 10, 2016 Apr 18 2016
Impax to Report First Quarter 2016 Results on May 10, 2016 Apr 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)